- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05066880
Yoga and Aerobic Exercise in Epilepsy
May 15, 2024 updated by: Burcin Aktar, Dokuz Eylul University
Investigation of the Effects of Yoga and Aerobic Exercise Training on Physical and Mental Health in People With Epilepsy
In recent years, there is growing interest in illustrating the health benefits of exercise among epilepsy.
Although exercise is recommended for patients with epilepsy, there is uncertainty concerning the effects of yoga and aerobic exercise on multiple health outcomes in epilepsy.
The aim of this trial is to examine the effects of yoga and aerobic exercise training on physical activity, health-related physical fitness, mental, emotional, and psychological health status, seizure frequency and quality of life.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Izmir, Turkey
- Dokuz Eylül University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients with epilepsy diagnosed by a neurologist using the International League Against Epilepsy (ILAE) criteria,
- Having access to the internet at least three per week.
Exclusion Criteria:
- Any history of neurological disorders other than epilepsy,
- Significant physical and cognitive impairments,
- Musculoskeletal comorbid conditions,
- Contraindications for an exercise intervention including diagnosed cardiovascular, pulmonary, or endocrine diseases,
- Pregnancy,
- Mental deficiency or low education level to understand the questionnaires,
- Currently participating in an exercise program,
- Volunteers who miss 3 consecutive intervention sessions, and do not participate in 10% of sessions.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Yoga
Participants allocated to the yoga group will receive the yoga-based intervention through an internet-based video conference remotely in real-time.
Each class will accommodate a maximum of 5 subjects.
A qualified physiotherapist who was a certificated yoga instructor will teach in these classrooms.
The 8-week exercise intervention consists of three times per week sessions of yoga.
|
Exercise training for 8 weeks
|
|
Experimental: Aerobic exercise
Participants of the aerobic exercise group will be requested to perform unsupervised aerobic training in the home environment (e.g., at home, park, backyard, or in the local gym).
The 8-week exercise intervention consists of three times per week sessions of aerobic exercise.
Training will consist of a 10-min warm-up period, aerobic activity, and 5-min cool-down period.
|
Exercise training for 8 weeks
|
|
No Intervention: Wait-list
Participants in the wait-list group will be advised to continue their habitual physical activity next to usual medical care.
A yoga or aerobic exercise program of 8 weeks will be offered after the ending of the study period.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physical activity in daily life
Time Frame: change from baseline to 8 weeks
|
Physical activity will be objectively monitored with an accelerometer.
|
change from baseline to 8 weeks
|
|
Seizure
Time Frame: change from baseline to 8 weeks
|
Participants will be given a seizure diary and requested to record the number of their seizure.
|
change from baseline to 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Six-Minute Walk test
Time Frame: change from baseline to 8 weeks
|
The Six-Minute Walk test will be used to determine functional capacity.
|
change from baseline to 8 weeks
|
|
30-second Chair Stand test
Time Frame: change from baseline to 8 weeks
|
Lower body strength will be determined using the 30-second Chair Stand test.
|
change from baseline to 8 weeks
|
|
Biodex Balance System
Time Frame: change from baseline to 8 weeks
|
Balance evaluation will be performed with Biodex Balance System.
|
change from baseline to 8 weeks
|
|
Bioelectrical impedance analyzer
Time Frame: change from baseline to 8 weeks
|
Body composition measurements will be performed with bioelectrical impedance analyzer.
|
change from baseline to 8 weeks
|
|
Waist and hip circumference
Time Frame: change from baseline to 8 weeks
|
For the anthropometric measurements, waist and hip circumference will be taken.
|
change from baseline to 8 weeks
|
|
Trail Making test and Digit Span test
Time Frame: change from baseline to 8 weeks
|
The Trail Making test and Digit Span test will be used to evaluate for attention.
|
change from baseline to 8 weeks
|
|
Stroop test and Verbal Fluency
Time Frame: change from baseline to 8 weeks
|
The Stroop test and Verbal Fluency will be used to evaluate for executive functions.
|
change from baseline to 8 weeks
|
|
Weschler Memory Scale-Revised Visual Reproduction subtest
Time Frame: change from baseline to 8 weeks
|
The Weschler Memory Scale-Revised Visual Reproduction subtest will be used to evaluate for visual memory.
|
change from baseline to 8 weeks
|
|
Clock Drawing test
Time Frame: change from baseline to 8 weeks
|
The Clock Drawing test will be used to evaluate for visual perception and visual-spatial functions.
|
change from baseline to 8 weeks
|
|
Oktem Verbal Memory Processes test
Time Frame: change from baseline to 8 weeks
|
The Oktem Verbal Memory Processes test will be used to evaluate for verbal memory performance.
|
change from baseline to 8 weeks
|
|
Neurological Disorders Depression Inventory for Epilepsy
Time Frame: change from baseline to 8 weeks
|
The Neurological Disorders Depression Inventory for Epilepsy will be used to evaluate for depression.
|
change from baseline to 8 weeks
|
|
Generalized Anxiety Disorder-7
Time Frame: change from baseline to 8 weeks
|
Anxiety will be determined by the Generalized Anxiety Disorder-7.
|
change from baseline to 8 weeks
|
|
10-item Perceived Stress Scale
Time Frame: change from baseline to 8 weeks
|
The 10-item Perceived Stress Scale will be used to assess subjective stress.
|
change from baseline to 8 weeks
|
|
Fatigue Impact Scale
Time Frame: change from baseline to 8 weeks
|
Fatigue will be assessed with the Fatigue Impact Scale.
|
change from baseline to 8 weeks
|
|
Pittsburg Sleep Quality Index
Time Frame: change from baseline to 8 weeks
|
Sleep quality will be measured using the Pittsburg Sleep Quality Index.
|
change from baseline to 8 weeks
|
|
Quality of Life in Epilepsy Inventory-31
Time Frame: change from baseline to 8 weeks
|
It will be used to determine health-related quality of life for epilepsy.
|
change from baseline to 8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 7, 2021
Primary Completion (Actual)
January 1, 2024
Study Completion (Actual)
May 1, 2024
Study Registration Dates
First Submitted
September 23, 2021
First Submitted That Met QC Criteria
September 23, 2021
First Posted (Actual)
October 4, 2021
Study Record Updates
Last Update Posted (Actual)
May 16, 2024
Last Update Submitted That Met QC Criteria
May 15, 2024
Last Verified
December 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 5258-GOA
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Epilepsy
-
NaviFUS CorporationTaipei Veterans General Hospital, TaiwanCompletedDrug Resistant Epilepsy | Epilepsy, Drug Resistant | Intractable Epilepsy | Refractory Epilepsy | Drug Refractory Epilepsy | Epilepsy, Drug Refractory | Epilepsy, Intractable | Medication Resistant EpilepsyTaiwan
-
Great Ormond Street Hospital for Children NHS Foundation...Active, not recruitingEpilepsies, Partial | Intractable Epilepsy | Focal Epilepsy | Refractory Epilepsy | Epilepsy Intractable | Epilepsy in Children | Epilepsy, FocalUnited Kingdom
-
University of British ColumbiaTerminatedJuvenile Myoclonic Epilepsy | Childhood Absence Epilepsy | Juvenile Absence EpilepsyCanada
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
UCB Pharma SACompletedEpilepsy, Tonic-clonicPoland, Sweden, Hungary, Czechia
-
UCB PharmaCompletedEpilepsy, Tonic-clonic
-
Oslo University HospitalCompletedEpilepsy | Generalized Epilepsy | Focal EpilepsyNorway
-
Institute of Child HealthGreat Ormond Street Hospital for Children NHS Foundation TrustNot yet recruitingEpilepsy Intractable | Epilepsy in Children
-
Massachusetts General HospitalBoston University; National Institute of Neurological Disorders and Stroke...CompletedEpilepsy | Epilepsy; Seizure | Rolandic Epilepsy | Rolandic Epilepsy, Benign | Centrotemporal Epilepsy | Centrotemporal; EEG Spikes, Epilepsy of ChildhoodUnited States
-
University Hospital, LilleCompletedFocal Epilepsy | Epilepsy IntractableFrance
Clinical Trials on Exercise training
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloCompleted
-
University of British ColumbiaMichael Smith Foundation for Health ResearchCompleted
-
Universidade Norte do ParanáCompleted
-
Universita di VeronaRecruiting
-
University of Colorado, DenverVA Eastern Colorado Health Care SystemCompletedHealthy | Overweight | Type 2 Diabetes Mellitus | Cardiovascular Risk FactorUnited States
-
National Taiwan University HospitalCompletedAtrial FibrillationTaiwan
-
Hacettepe UniversityCompleted
-
University of LeipzigCompletedImpact of Intensive Exercise Training on Coronary Collateral Circulation in Patients With Stable CADStable Coronary Artery DiseaseGermany
-
Helse Stavanger HFStavanger Health ResearchCompletedVentricular TachycardiaNorway
-
Toronto Rehabilitation InstituteCompletedAcute Myeloid LeukemiaCanada